Data as of Jan 30
| -1.03 / -3.15%|
The 4 analysts offering 12-month price forecasts for Medifast Inc have a median target of 32.50, with a high estimate of 33.00 and a low estimate of 27.86. The median estimate represents a +2.56% increase from the last price of 31.69.
The current consensus among 4 polled investment analysts is to Hold stock in Medifast Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.